TY - JOUR
T1 - Stem cells for the treatment of urinary incontinence
AU - Staack, Andrea
AU - Rodríguez, Larissa V.
N1 - Funding Information:
Disclosures Dr. A. Staack: none. Dr. Larissa Rodríguez has served as a consultant for Astellas Pharma, has received grants from the National Institutes of Health, and has received royalties from Elsevier.
PY - 2011/2
Y1 - 2011/2
N2 - Stress urinary incontinence (SUI) is highly prevalent. As of now, there is no minimally invasive long-term treatment available. Adult stem cells are nonimmunogenic and have the ability to self-renew and to differentiate into multiple cell types. Over the past decade, in vivo studies have described periurethral injections of adult-derived stem cells for the treatment of SUI. The ultimate goal has been to achieve a permanent cure for SUI by restoration of the intrinsic and extrinsic urethral sphincter and the surrounding connective tissue, including peripheral nerves and blood vessels. For this purpose, future studies need to focus on delivery systems, cell survival, and functional improvement of the urethral closure mechanism, including improvement of innervation and vascularization. © 2010 The Author(s).
AB - Stress urinary incontinence (SUI) is highly prevalent. As of now, there is no minimally invasive long-term treatment available. Adult stem cells are nonimmunogenic and have the ability to self-renew and to differentiate into multiple cell types. Over the past decade, in vivo studies have described periurethral injections of adult-derived stem cells for the treatment of SUI. The ultimate goal has been to achieve a permanent cure for SUI by restoration of the intrinsic and extrinsic urethral sphincter and the surrounding connective tissue, including peripheral nerves and blood vessels. For this purpose, future studies need to focus on delivery systems, cell survival, and functional improvement of the urethral closure mechanism, including improvement of innervation and vascularization. © 2010 The Author(s).
KW - Adipose-derived stem cells
KW - Adult stem cell therapy
KW - Bone marrow-derived stem cells
KW - Mesenchymal-derived stem cells
KW - Muscular-derived stem cells
KW - Periurethral injection
KW - Stress urinary incontinence
UR - https://www.scopus.com/pages/publications/79551512855
UR - https://www.scopus.com/pages/publications/79551512855#tab=citedBy
UR - https://www.mendeley.com/catalogue/0788097a-c5bc-3d79-9310-e011e3f9f11d/
U2 - 10.1007/s11934-010-0155-z
DO - 10.1007/s11934-010-0155-z
M3 - Article
C2 - 21113694
SN - 1527-2737
VL - 12
SP - 41
EP - 46
JO - Current Urology Reports
JF - Current Urology Reports
IS - 1
ER -